[1]
H. Al-Momen, “Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study”, Al-Kindy Col. Med. J, vol. 13, no. 1, pp. 76–81, Apr. 2019, doi: 10.47723/kcmj.v13i1.130.